Previous research has shown that ACSL5 may be vital to the malignant progression and metastasis of gliomas, and this supports targeting ACSL5 as a potentially effective treatment strategy (Sebastiano and Konstantinidou, 2019). The gene discussed is ACSL5; the disease is glioma.